Recombinant Human CD52 Fc Chimera Protein, CF Summary
Siglec‑10 Fc Chimera (Catalog # 2130-SL) that produces 50% of the optimal binding response is approximately 1-5 μg/mL.
Accession # P31358
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 200 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
CD52, also known as CAMPATH-1 antigen, HE5, and gp20, is a cell surface glycoprotein that can be targeted to induce immune suppression by complement-mediated cell lysis (1, 2). Mature human CD52 is a 12 amino acid peptide that is tethered to the cell surface with a GPI linkage (3). It carries a large tissue-specific carbohydrate structure which increases the molecular weight of CD52 to 15-20 kDa (3-5). CD52 is expressed on lymphocytes, monocytes, monocycte-derived dendritic cells, eosinophils, and neutrophils (6-8), as well as on mature spermatozoa and epithelial cells lining the male genital tract (5, 9, 10). It protects sperm against anti-sperm antibodies by binding to C1q and inhibiting complement activation (11). CD52 ligation on CD4+ T cells induces a suppressive population of cells that release soluble CD52 which then binds to Siglec-10 (12-14). This interaction inhibits the proliferation of activated T cells and the cytotoxic function of autoimmune CD8+ T cells in type 1 diabetes (13).
- Morris, P.J. and N.K. Russell (2006) Transplantation 81:1361.
- Redpath, S. et al. (1998) Immunology 93:595.
- Xia, M.Q. et al. (1991) Eur. J. Immunol. 21:1677.
- Treumann, A. et al. (1995) J. Biol. Chem. 270:6088.
- Schroter, S. et al. (1999) J. Biol. Chem. 274:29862.
- Ratzinger, G. et al. (2003) Blood 101:1422.
- Elsner, J. et al. (1996) Blood 88:4684.
- Ambrose, L.R. et al. (2009) Blood 114:3052.
- Focarelli, R et al. (1998) Mol. Hum. Reprod. 4:119.
- Hale, G. et al. (1993) J. Reprod. Immunol. 23:189.
- Hardiyanto, L. et al. (2012) J. Reprod. Immunol. 94:142.
- Watanabe, T. et al. (2006) Clin. Immunol. 120:247.
- Bandala-Sanchez, E. et al. (2013) Nat. Immunol. 14:741.
- Toh, B.-H. et al. (2013) Cell. Mol. Immunol. 10:379.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human CD52 Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human CD52 Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Human CD52 Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image